rs1049524

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_004172.5(SLC1A3):​c.*1022G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.317 in 152,136 control chromosomes in the GnomAD database, including 9,463 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.32 ( 9462 hom., cov: 33)
Exomes 𝑓: 0.43 ( 1 hom. )

Consequence

SLC1A3
NM_004172.5 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 0.0870

Publications

9 publications found
Variant links:
Genes affected
SLC1A3 (HGNC:10941): (solute carrier family 1 member 3) This gene encodes a member of a member of a high affinity glutamate transporter family. This gene functions in the termination of excitatory neurotransmission in central nervous system. Mutations are associated with episodic ataxia, Type 6. Alternative splicing results in multiple transcript variants.[provided by RefSeq, Feb 2014]
SLC1A3-AS1 (HGNC:56374): (SLC1A3 antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 5-36687291-G-A is Benign according to our data. Variant chr5-36687291-G-A is described in ClinVar as Benign. ClinVar VariationId is 353344.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.495 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SLC1A3NM_004172.5 linkc.*1022G>A 3_prime_UTR_variant Exon 10 of 10 ENST00000265113.9 NP_004163.3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SLC1A3ENST00000265113.9 linkc.*1022G>A 3_prime_UTR_variant Exon 10 of 10 1 NM_004172.5 ENSP00000265113.4

Frequencies

GnomAD3 genomes
AF:
0.317
AC:
48195
AN:
152004
Hom.:
9468
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0819
Gnomad AMI
AF:
0.426
Gnomad AMR
AF:
0.298
Gnomad ASJ
AF:
0.456
Gnomad EAS
AF:
0.443
Gnomad SAS
AF:
0.511
Gnomad FIN
AF:
0.343
Gnomad MID
AF:
0.386
Gnomad NFE
AF:
0.428
Gnomad OTH
AF:
0.338
GnomAD4 exome
AF:
0.429
AC:
6
AN:
14
Hom.:
1
Cov.:
0
AF XY:
0.500
AC XY:
4
AN XY:
8
show subpopulations
African (AFR)
AC:
0
AN:
0
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
2
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
0.500
AC:
5
AN:
10
Other (OTH)
AF:
0.500
AC:
1
AN:
2
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.317
AC:
48181
AN:
152122
Hom.:
9462
Cov.:
33
AF XY:
0.318
AC XY:
23602
AN XY:
74332
show subpopulations
African (AFR)
AF:
0.0817
AC:
3392
AN:
41522
American (AMR)
AF:
0.297
AC:
4545
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.456
AC:
1583
AN:
3472
East Asian (EAS)
AF:
0.443
AC:
2288
AN:
5166
South Asian (SAS)
AF:
0.511
AC:
2464
AN:
4818
European-Finnish (FIN)
AF:
0.343
AC:
3627
AN:
10574
Middle Eastern (MID)
AF:
0.381
AC:
112
AN:
294
European-Non Finnish (NFE)
AF:
0.428
AC:
29070
AN:
67974
Other (OTH)
AF:
0.338
AC:
712
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1552
3104
4656
6208
7760
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
490
980
1470
1960
2450
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.368
Hom.:
4195
Bravo
AF:
0.300
Asia WGS
AF:
0.445
AC:
1549
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:1
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Episodic ataxia type 6 Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.82
CADD
Benign
1.5
DANN
Benign
0.71
PhyloP100
0.087
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1049524; hg19: chr5-36687393; API